Dr. Kate Rowley is passionate about investing in and growing companies that deliver innovative healthcare technologies into the hands of patients, physicians and users to advance global health and well being.
Kate has a specific interest in medtech and molecular technologies.
Role
Dr. Kate Rowley has joined BSM as an Investment Director based in London, her role will be portfolio management in addition to evaluating healthcare investment opportunities and managing investment deals from across the globe, in particular the UK and Europe.
Experience
Kate has over 20 years of life science experience working within small healthcare and large pharma companies and the public sector. Prior to joining BSM she spent 5 years as a Healthcare Investor Director focused on deal origination, prospective investment company due diligence, deal negotiation and portfolio management, sitting on the boards of 5 Healthcare companies. She also has experience of the clinical drug development sector in her role as Executive Director leading business development across Europe.
Qualifications
Kate received her PhD in Molecular Virology from the University of Reading, an MBA from the University of Glasgow and a BSc Honours (First Class) in Applied Microbiology and Bio technology from the University of Sunderland.
